ConductScience.org, home

Paper3396952

Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up.

O'Donnell LD and 1 other. Gut, 1988. Cited by 140 papers, by iCite.

Cite this record

ConductScience Library. Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up. Papers, record 3396952. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3396952

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up.
PubMed
Journal
Gut
PubMed
Year
1988
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
140
iCite
Relative citation ratio, by iCite
8.08
iCite
Revised in PubMed
2019-05-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1O'Donnell LDL D
2Heaton KWK W

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chenodeoxycholic AcidMajor topic
CholelithiasisMajor topic
Deoxycholic AcidMajor topic
Ursodeoxycholic AcidMajor topic
Adult
Aged
Aged, 80 and over
Female
Follow-Up Studies
Humans
Male
Middle Aged
Prognosis
Recurrence

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11152936Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.N Engl J Med1975https://conductscience.org/library/papers/1152936PubMed
24135688Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones.Lancet1974https://conductscience.org/library/papers/4135688PubMed
3838406Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?Gut1977https://conductscience.org/library/papers/838406PubMed
4467918Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.Gastroenterology1979https://conductscience.org/library/papers/467918PubMed
57023307Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety.Ann Intern Med1981https://conductscience.org/library/papers/7023307PubMed
66119557Is recurrence inevitable after gallstone dissolution by bile-acid treatment?Lancet1982https://conductscience.org/library/papers/6119557PubMed
77062856Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence.Medicine (Baltimore)1982https://conductscience.org/library/papers/7062856PubMed
87094795Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I.Dig Dis Sci1982https://conductscience.org/library/papers/7094795PubMed
96884705Evidence for a potent nucleating factor in the gallbladder bile of patients with cholesterol gallstones.Gastroenterology1983https://conductscience.org/library/papers/6884705PubMed
106329890Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying.Gastroenterology1984https://conductscience.org/library/papers/6329890PubMed
113967810Abnormal gallbladder emptying in a subgroup of patients with gallstones.Gastroenterology1985https://conductscience.org/library/papers/3967810PubMed
123902954Discrepancies between cholecystography and ultrasonography in the detection of recurrent gallstones.J Hepatol1985https://conductscience.org/library/papers/3902954PubMed
133699565Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.Gut1986https://conductscience.org/library/papers/3699565PubMed
143540098Gallstone recurrence after medical dissolution. An overestimated threat?J Hepatol1986https://conductscience.org/library/papers/3540098PubMed
155006919Dissolution of cholesterol gallstones by chenodeoxycholic acid.N Engl J Med1972https://conductscience.org/library/papers/5006919PubMed
164117706Gallstone dissolution in man using chenodeoxycholic acid.Lancet1972https://conductscience.org/library/papers/4117706PubMed
179338Presence or absence of inhibitors of crystal growth in bile. 1. Effect of bile on the formation of calcium phosphate, a constituent of gallstones.Gut1976https://conductscience.org/library/papers/9338PubMed

Download CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.

PMIDTitleJournalYearIn PapersSource
31660031Superior gallstone dissolubility and safety of tert-amyl ethyl ether over methyl-tertiary butyl ether.World J Gastroenterol2019https://conductscience.org/library/papers/31660031PubMed
30197485Percutaneous transhepatic extraction and balloon dilation for simultaneous gallbladder stones and common bile duct stones: A novel technique.World J Gastroenterol2018https://conductscience.org/library/papers/30197485PubMed
16041208Postoperative ERCP versus laparoscopic choledochotomy for clearance of selected bile duct calculi: a randomized trial.Ann Surg2005https://conductscience.org/library/papers/16041208PubMed
15628729Predictions and associations of cholecystectomy in patients with cholecystolithiasis treated with extracorporeal shock wave lithotripsy.Dig Dis Sci2004https://conductscience.org/library/papers/15628729PubMed
11819380Multifactorial analysis of recurrence of cholecy_stolithiasis in Shanghai area.World J Gastroenterol1999https://conductscience.org/library/papers/11819380PubMed
9590398Dissolution of gallbladder stones with methyl tert-butyl ether and stone recurrence: a European survey.Dig Dis Sci1998https://conductscience.org/library/papers/9590398PubMed
8601364Gallstone recurrence after successful dissolution therapy.Dig Dis Sci1996https://conductscience.org/library/papers/8601364PubMed
8536514Gallbladder stone recurrence after medical treatment. Do gallstones recur true to type?Dig Dis Sci1995https://conductscience.org/library/papers/8536514PubMed
8491387Gall stones and gall bladder motility.Gut1993https://conductscience.org/library/papers/8491387PubMed
8407258Current alternatives to open cholecystectomy in the management of gallstones.Ir J Med Sci1993https://conductscience.org/library/papers/8407258PubMed
8406169Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.Gut1993https://conductscience.org/library/papers/8406169PubMed
8307431Gall stone pulverisation strategy in patients treated with extracorporeal lithotripsy and follow up results of maintenance treatment with ursodeoxycholic acid.Gut1994https://conductscience.org/library/papers/8307431PubMed
8273387Role of extracorporeal shock wave lithotripsy in hepato-biliary-pancreatic surgery.World J Surg1993https://conductscience.org/library/papers/8273387PubMed
8200568Percutaneous cholecystolithotomy: is gall stone recurrence inevitable?Gut1994https://conductscience.org/library/papers/8200568PubMed
7648980Effect of aspirin on gallbladder motility in patients with gallstone disease. A randomized, double-blind, placebo-controlled trial of two dosage schedules.Dig Dis Sci1995https://conductscience.org/library/papers/7648980PubMed
7648979Gallstone recurrence after direct contact dissolution with methyl tert-butyl ether.Dig Dis Sci1995https://conductscience.org/library/papers/7648979PubMed
7514975Pharmacological treatment of gallstones. Practical guidelines.Drugs1994https://conductscience.org/library/papers/7514975PubMed
2680747Extracorporeal biliary lithotripsy and direct chemolitholysis-an integrated concept.Gastroenterol Jpn1989https://conductscience.org/library/papers/2680747PubMed
2598767Postdissolution gallstone recurrence. A clinical perspective.Dig Dis Sci1989https://conductscience.org/library/papers/2598767PubMed
2040478Persistence of symptoms after gall bladder clearance with cholecystolithotripsy.Gut1991https://conductscience.org/library/papers/2040478PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3396952

GET https://conductscience.org/api/papers/v1/3396952/cited_by?page=2